The Medical Foundation: Why GLP-1 Medications Represent a Paradigm Shift According to medical literature and FDA approval documentation, GLP-1 receptor agonist medications represent the most significant pharmacological advancement in obesity medicine in decades
Do I need to count calories on Mounjaro or Wegovy
Functional elements of the gastric inhibitory polypeptide receptor: Comparison between secretin- and rhodopsin-like G protein-coupled receptors
People taking these medicines may require dose adjustments to their existing treatments under medical supervision
Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People With Type 2 Diabetes: A Randomised, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Phase 2 Trial
GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity